Patients with autoimmune diseases (e.g., RA, SLE, MS, and T1D) have lower levels of CTLA-4 mRNA and protein in their PBMC, spleen, and lymph nodes than healthy subjects (Table 1). This evidence concerns the gene CTLA4 and rheumatoid arthritis.